|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.580 USD | -4.02% |
|
-11.17% | +6.23% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Revenues | 415M | 592M | 1.6B | 2.02B | 1.93B | ||||
Other Revenues, Total | - | 65.42M | 32.28M | 39M | 60.65M | ||||
Total Revenues | 415M | 657M | 1.64B | 2.06B | 1.99B | ||||
Cost of Goods Sold, Total | 443M | 674M | 1.59B | 2.03B | 1.86B | ||||
Gross Profit | -27.41M | -16.3M | 47.72M | 25.44M | 137M | ||||
Selling General & Admin Expenses, Total | 1.06B | 617M | 373M | 401M | 401M | ||||
Provision for Bad Debts | - | 91.59M | -687K | 13.84M | -380K | ||||
R&D Expenses | 125M | 74.14M | 36.2M | 37.7M | 10.85M | ||||
Other Operating Expenses | -224M | -246M | -82.02M | -69.99M | -42.24M | ||||
Other Operating Expenses, Total | 958M | 536M | 327M | 382M | 369M | ||||
Operating Income | -986M | -553M | -279M | -357M | -233M | ||||
Interest Expense, Total | -116M | -95.95M | -41.22M | -21.24M | -92.08M | ||||
Interest And Investment Income | 12.32M | 45.14M | 3.66M | 10.98M | 49.33K | ||||
Net Interest Expenses | -104M | -50.81M | -37.56M | -10.27M | -92.03M | ||||
Income (Loss) On Equity Invest. | 27.76M | 15.66M | 328K | -44K | 3.24M | ||||
Currency Exchange Gains (Loss) | -1.55M | -15.89M | -9.34M | -2.46M | 372K | ||||
Other Non Operating Income (Expenses) | -30.79M | -113M | -3.7M | -7.06M | 8.41M | ||||
EBT, Excl. Unusual Items | -1.09B | -717M | -329M | -377M | -313M | ||||
Gain (Loss) On Sale Of Investments | - | - | 186M | 243M | -11.78M | ||||
Gain (Loss) On Sale Of Assets | 716M | - | - | - | - | ||||
Other Unusual Items | -7.76B | - | - | -2.78M | 46.96M | ||||
EBT, Incl. Unusual Items | -8.14B | -717M | -143M | -137M | -266M | ||||
Income Tax Expense | 1.3M | 33K | 245K | 366K | 52K | ||||
Earnings From Continuing Operations | -8.14B | -717M | -143M | -137M | -266M | ||||
Earnings Of Discontinued Operations | -1.82B | 296M | - | - | - | ||||
Net Income to Company | -9.96B | -421M | -143M | -137M | -266M | ||||
Minority Interest | 21.53M | 9K | - | 12K | -6.64M | ||||
Net Income - (IS) | -9.94B | -421M | -143M | -137M | -272M | ||||
Preferred Dividend and Other Adjustments | - | - | - | 756M | 2.06B | ||||
Net Income to Common Incl Extra Items | -9.94B | -421M | -143M | -893M | -272M | ||||
Net Income to Common Excl. Extra Items | -8.12B | -717M | -143M | -893M | -272M | ||||
Per Share Items | |||||||||
Net EPS - Basic | -3.36K | -114.81 | -36.77 | -199.2 | -333.55 | ||||
Basic EPS - Continuing Operations | -2.74K | -195.42 | -36.77 | -199.2 | -333.55 | ||||
Basic Weighted Average Shares Outstanding | 2.96M | 3.67M | 3.89M | 4.48M | 189M | ||||
Net EPS - Diluted | -3.36K | -114.81 | -622.14 | -199.2 | -333.55 | ||||
Diluted EPS - Continuing Operations | -2.74K | -195.42 | -622.14 | -199.2 | -333.55 | ||||
Diluted Weighted Average Shares Outstanding | 2.96M | 3.67M | 4.52M | 4.48M | 189M | ||||
Normalized Basic EPS | -223.61 | -122.13 | -52.83 | -52.54 | -30.67 | ||||
Normalized Diluted EPS | -223.61 | -122.13 | -45.57 | -52.54 | -30.67 | ||||
American Depositary Receipts Ratio (ADR) | 300 | 300 | 300 | 300 | 300 | ||||
Supplemental Items | |||||||||
EBITDA | -900M | -506M | -265M | -344M | -222M | ||||
EBITA | -985M | -553M | -279M | -357M | -233M | ||||
EBIT | -986M | -553M | -279M | -357M | -233M | ||||
EBITDAR | -211M | -465M | -242M | -314M | -145M | ||||
Total Revenues (As Reported) | - | 657M | 1.64B | 2.06B | 1.99B | ||||
Effective Tax Rate - (Ratio) | -0.02 | -0 | -0.17 | -0.27 | -0.02 | ||||
Total Current Taxes | 1.3M | 33K | 245K | 366K | 52K | ||||
Total Deferred Taxes | - | - | - | - | - | ||||
Normalized Net Income | -662M | -448M | -206M | -235M | -202M | ||||
Supplemental Operating Expense Items | |||||||||
Advertising Expense | - | - | 58.7M | 46.9M | 15.8M | ||||
Marketing Expenses | - | - | - | - | - | ||||
Selling and Marketing Expenses | 758M | 339M | 222M | 236M | 236M | ||||
General and Administrative Expenses | 300M | 278M | 151M | 165M | 165M | ||||
Research And Development Expense From Footnotes | 125M | 74.14M | 36.2M | 37.7M | 10.85M | ||||
Net Rental Expense, Total | 14.3M | 41.4M | 23.1M | 29.3M | 20.97M | ||||
Imputed Operating Lease Interest Expense | - | 14.39M | 4.84M | 4.99M | 9.85M | ||||
Imputed Operating Lease Depreciation | - | 27.01M | 18.26M | 24.31M | 15.72M | ||||
Stock-Based Comp., R&D Exp. (Total) | - | - | - | 1.71M | 171K | ||||
Stock-Based Comp., S&M Exp. (Total) | - | - | - | 1.52M | 181K | ||||
Stock-Based Comp., G&A Exp. (Total) | - | - | 26.53M | 44.09M | 113M | ||||
Stock-Based Comp., Other (Total) | -130M | -19.12M | - | - | - | ||||
Total Stock-Based Compensation | -130M | -19.12M | 26.53M | 47.31M | 113M |
- Stock Market
- Equities
- UXIN Stock
- Financials Uxin Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















